相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dichotomous regulation of striatal plasticity by dynorphin
Renzhi Yang et al.
MOLECULAR PSYCHIATRY (2023)
Using PCG-Arginine nanoparticle mediated intranasal delivery of dynorphin A (1-8) to improve neuroprotection in MCAO rats
Mengying Chen et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2022)
Endogenous Opioid Dynorphin Is a Potential Link between Traumatic Brain Injury, Chronic Pain, and Substance Use Disorder
Kaitlin M. Best et al.
JOURNAL OF NEUROTRAUMA (2022)
Dynorphin A induces membrane permeabilization by formation of proteolipidic pores. Insights from electrophysiology and computational simulations
D. Aurora Perini et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)
The dynorphin/kappa opioid receptor mediates adverse immunological and behavioral outcomes induced by repetitive blast trauma
Suhjung Janet Lee et al.
JOURNAL OF NEUROINFLAMMATION (2022)
Intracerebroventricular Administration of Dermorphin-Dynorphin Analogs Producing Antidepressant-Like Effects through Activation of μ<sub>1</sub>- and κ-Opioid Receptors in Mice
Osamu Nakagawasai et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2022)
Dynorphin/KOR inhibits neuronal autophagy by activating mTOR signaling pathway to prevent acute seizure epilepsy
Lin Liu et al.
CELL BIOLOGY INTERNATIONAL (2022)
Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders
Aaron Limoges et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2022)
Conformational Constraint between Aromatic Residue Side Chains in the Message Sequence of the Peptide Arodyn Using Ring Closing Metathesis Results in a Potent and Selective Kappa Opioid Receptor Antagonist
Solomon A. Gisemba et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Improving the Utility of a Dynorphin Peptide Analogue Using Mannosylated Glycoliposomes
Jordan D. Lewicky et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain
Edin Muratspahic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Analogs of the κ opioid receptor antagonist arodyn cyclized by ring-closing metathesis retain κ opioid receptor affinity, selectivity and κ opioid receptor antagonism
Wei-Jie Fang et al.
MEDICINAL CHEMISTRY RESEARCH (2021)
Mannosylated glycoliposomes for the delivery of a peptide kappa opioid receptor antagonist to the brain
Jordan D. Lewicky et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Food-Derived Opioid Peptides in Human Health: A Review
Akanksha Tyagi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A new painkiller nanomedicine to bypass the blood-brain barrier and the use of morphine
Jiao Feng et al.
SCIENCE ADVANCES (2019)
Design, synthesis, and opioid activity of arodyn analogs cyclized by ring-closing metathesis involving Tyr(allyl)
Wei-Jie Fang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
New concepts in opioid analgesia
Christoph Stein
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
The efficacy of Dynorphin fragments at the κ, μ and δ opioid receptor in transfected HEK cells and in an animal model of unilateral peripheral inflammation
M. Morgan et al.
PEPTIDES (2017)
Inhibitory effects of dynorphin 3-14 on the lipopolysaccharide-induced toll-like receptor 4 signalling pathway
Siti Sarah Fazalul Rahiman et al.
PEPTIDES (2017)
Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain
Sara M. Hall et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Cyclic non-opioid dynorphin A analogues for the bradykinin receptors
Yeon Sun Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Dynorphin A analogs for the treatment of chronic neuropathic pain
Sara M. Hall et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Structure-Activity Relationships of [des-Arg7]Dynorphin A Analogues at the κ Opioid Receptor
Cyf N. Ramos-Colon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment
Leona Wagner et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Dynorphin 1-17 and Its N-Terminal Biotransformation Fragments Modulate Lipopolysaccharide-Stimulated Nuclear Factor-kappa B Nuclear Translocation, Interleukin-1beta and Tumor Necrosis Factor-alpha in Differentiated THP-1 Cells
Siti Sarah Fazalul Rahiman et al.
PLOS ONE (2016)
Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin
Anand A. Joshi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Effect of three peptidase inhibitors on antinociceptive potential and toxicity with intracerebroventricular administration of dynorphin A (1-17) or (1-13) in the rat
Junko Ajimi et al.
JOURNAL OF ANESTHESIA (2015)
Neuropeptides: Metabolism to Bioactive Fragments and the Pharmacology of Their Receptors
Mathias Hallberg
MEDICINAL RESEARCH REVIEWS (2015)
Structure-activity relationships of non-opioid [des-Arg7]-dynorphin A analogues for bradykinin receptors
Yeon Sun Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Discovery of Amphipathic Dynorphin A Analogues to Inhibit the Neuroexcitatory Effects of Dynorphin A through Bradykinin Receptors in the Spinal Cord
Yeon Sun Lee et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Biotransformation of beta-endorphin and possible therapeutic implications
Naghmeh H. Asvadi et al.
FRONTIERS IN PHARMACOLOGY (2014)
Dynorphin A 1-17 biotransformation in inflamed tissue, serum and trypsin solution analysed by liquid chromatography-tandem mass spectrometry
M. Morgan et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
Pain inhibition by blocking leukocytic and neuronal opioid peptidases in peripheral inflamed tissue
Anja Schreiter et al.
FASEB JOURNAL (2012)
Why in vivo may not equal in vitro - new effectors revealed by measurement of enzymatic activities under the same in vivo-like assay conditions
Rodolfo Garcia-Contreras et al.
FEBS JOURNAL (2012)
Endogenous opioid systems Current concepts and clinical correlations
Eduardo E. Benarroch
NEUROLOGY (2012)
Perivascular Expression and Potent Vasoconstrictor Effect of Dynorphin A in Cerebral Arteries
Eva Ruisanchez et al.
PLOS ONE (2012)
The permeation of dynorphin A 1-6 across the blood brain barrier and its effect on bovine brain microvessel endothelial cell monolayer permeability
Courtney D. Kuhnline Sloan et al.
PEPTIDES (2012)
Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice
Koichi Tan-No et al.
NEUROPEPTIDES (2010)
Comparative studies of the neuro-excitatory behavioural effects of morphine-3-glucuronide and dynorphin A(2-17) following spinal and supraspinal routes of administration
Kamondanai Hemstapat et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action
Jane V. Aldrich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Cysteine protease inhibitors suppress the development of tolerance to morphine antinociception
Koichi Tan-No et al.
NEUROPEPTIDES (2008)
The enhancing effects of peptidase inhibitors on the antinociceptive action of [Met5]enkephalin-Arg6-Phe7 in rats
Shigeru Takahashi et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2007)
Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn
A. N. Carey et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Enzymatic conversion of dynorphin A in the rat brain is affected by administration of nandrolone decanoate
Kristina Magnusson et al.
PEPTIDES (2007)
Dynorphin displaces binding at the glycine site of the NMDA receptor in the rat striatum
Pieter Voorn et al.
NEUROSCIENCE LETTERS (2007)
Dynorphin A activates bradykinin receptors to maintain neuropathic pain
Josephine Lai et al.
NATURE NEUROSCIENCE (2006)
Translocation of dynorphin neuropeptides across the plasma membrane -: A putative mechanism of signal transmission
Z Marinova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
[Nα-BenzylTyr1,cyclo(D-Asp5,Dap8)]dynorphin A-(1-11)NH2 cyclized in the address domain is a novel K-opioid receptor antagonist
KA Patkar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Pronociceptive role of dynorphins in uninjured animals:: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation
K Tan-No et al.
PAIN (2005)
Altered extracellular striatal in vivo biotransformation of the opioid neuropeptide dynorphin A(1-17) in the unilateral 6-OHDA rat model of Parkinson's disease
R Klintenberg et al.
JOURNAL OF MASS SPECTROMETRY (2005)
Rethinking the renin-angiotensin system and its role in cardiovascular regulation
P Pagliaro et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Identification of stabilized dynorphin derivatives for suppressing tolerance in morphine-dependent rats
SI Al-Fayoumi et al.
PHARMACEUTICAL RESEARCH (2004)
Dynorphin-A(1-17) decreases nitric oxide release and cytotoxicity induced with lipopolysaccharide plus interferon-γ in murine macrophage cell line J774
J Gabrilovac et al.
BIOMEDICINE & PHARMACOTHERAPY (2003)
Dynorphin A(1-17) biotransformation in striatum of freely moving rats using microdialysis and matrix-assisted laser desorption/ionization mass spectrometry
B Reed et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Suppressed prolactin response to dynorphin A1-13 in methadone-maintained versus control subjects
G Bart et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Dipeptidyl peptidase IV (DPPIV) enzyme activity on immature T-cell line R1.1 is down-regulated by dynorphin-A(1-17) as a non-substrate inhibitor
J Gabrilovac et al.
LIFE SCIENCES (2003)
A novel N-terminal cyclic dynorphin a analogue cycloN,5[Trp3,Trp4,Glu5] dynorphin A-(1-11)NH2 that lacks the basic N-terminus
BS Vig et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Identification of arodyn, a novel acetylated dynorphin A-(1-11) analogue, as a κ opioid receptor antagonist
MA Bennett et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
[2′,6′-dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group:: Potent and selective κ opioid antagonists
YX Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain
PJ Cabot et al.
PAIN (2001)
Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg ψ (CH2NH) Arg-NH2, in mice
M Hiramatsu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Structure-activity analysis of dynorphin A toxicity in spinal cord neurons: Intrinsic neurotoxicity of dynorphin A and its carboxyl-terminal, nonopioid metabolites
KF Hauser et al.
EXPERIMENTAL NEUROLOGY (2001)
[Pro3]Dyn A(1-11)-NH2:: A dynorphin analogue with high selectivity for the κ opioid receptor
G Schlechtingen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
